MID1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.252600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.411400E-01
Normal-vs-Stage2
4.867400E-01
Normal-vs-Stage3
7.846600E-01
Normal-vs-Stage4
4.004600E-01
Stage1-vs-Stage2
8.749600E-01
Stage1-vs-Stage3
3.201000E-01
Stage1-vs-Stage4
5.192600E-01
Stage2-vs-Stage3
2.498600E-01
Stage2-vs-Stage4
4.912800E-01
Stage3-vs-Stage4
1.331960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.566400E-01
Normal-vs-AfricanAmerican
4.085400E-01
Normal-vs-Asian
4.654000E-01
Caucasian-vs-AfricanAmerican
4.916000E-01
Caucasian-vs-Asian
5.986400E-01
AfricanAmerican-vs-Asian
8.116800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.840000E-01
Normal-vs-Female
4.742400E-01
Male-vs-Female
3.333800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.402800E-01
Normal-vs-Age(41-60Yrs)
2.705200E-01
Normal-vs-Age(61-80Yrs)
6.543400E-01
Normal-vs-Age(81-100Yrs)
7.732200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.091800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.429200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.436800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.397100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.075790E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.553600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.398600E-01
Normal-vs-Daily Drinker
6.965200E-01
Normal-vs-Weekly Drinker
7.965800E-01
Normal-vs-Occasional Drinker
7.216200E-01
Normal-vs-Social Drinker
4.380000E-01
Non Drinker-vs-Daily Drinker
9.259000E-01
Non Drinker-vs-Weekly Drinker
8.185800E-01
Non Drinker-vs-Occasional Drinker
8.816800E-01
Non Drinker-vs-Social Drinker
3.369000E-01
Daily Drinker-vs-Weekly Drinker
7.508000E-01
Daily Drinker-vs-Occasional Drinker
8.048600E-01
Daily Drinker-vs-Social Drinker
3.863600E-01
Weekly Drinker-vs-Occasional Drinker
9.081600E-01
Weekly Drinker-vs-Social Drinker
2.688800E-01
Occasional Drinker-vs-Social Drinker
2.488200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.561400E-01
Normal-vs-Grade 2
8.138300E-02
Normal-vs-Grade 3
1.724360E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.136600E-01
Grade 1-vs-Grade 3
9.587400E-01
Grade 1-vs-Grade 4
2.561400E-01
Grade 2-vs-Grade 3
3.581200E-01
Grade 2-vs-Grade 4
8.138300E-02
Grade 3-vs-Grade 4
1.724360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.141000E-01
Normal-vs-NonDiabetic
5.757400E-01
Diabetic-vs-NonDiabetic
5.450200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.765400E-01
Normal-vs-NoPancreatitis
6.603800E-01
Pancreatitis-vs-NoPancreatitis
1.965210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.726800E-01
Normal-vs-N1
4.523000E-01
N0-vs-N1
2.294000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.882600E-01
Normal-vs-TP53-NonMutant
4.361600E-01
TP53-Mutant-vs-TP53-NonMutant
7.533000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
